AEterna Zentaris Inc (AEZS)
7.99
+0.19
(+2.44%)
USD |
NASDAQ |
May 06, 16:00
7.80
-0.19
(-2.38%)
After-Hours: 20:00
AEterna Zentaris Max Drawdown (5Y): 99.08% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.08% |
March 31, 2024 | 99.08% |
February 29, 2024 | 99.08% |
January 31, 2024 | 99.08% |
December 31, 2023 | 99.08% |
November 30, 2023 | 99.08% |
October 31, 2023 | 99.08% |
September 30, 2023 | 99.08% |
August 31, 2023 | 99.08% |
July 31, 2023 | 99.13% |
June 30, 2023 | 99.13% |
May 31, 2023 | 99.13% |
April 30, 2023 | 99.13% |
March 31, 2023 | 99.13% |
February 28, 2023 | 99.13% |
January 31, 2023 | 99.37% |
December 31, 2022 | 99.40% |
November 30, 2022 | 99.40% |
October 31, 2022 | 99.40% |
September 30, 2022 | 99.40% |
August 31, 2022 | 99.42% |
July 31, 2022 | 99.42% |
June 30, 2022 | 99.43% |
May 31, 2022 | 99.53% |
April 30, 2022 | 99.81% |
Date | Value |
---|---|
March 31, 2022 | 99.82% |
February 28, 2022 | 99.83% |
January 31, 2022 | 99.83% |
December 31, 2021 | 99.83% |
November 30, 2021 | 99.83% |
October 31, 2021 | 99.83% |
September 30, 2021 | 99.83% |
August 31, 2021 | 99.83% |
July 31, 2021 | 99.83% |
June 30, 2021 | 99.83% |
May 31, 2021 | 99.83% |
April 30, 2021 | 99.83% |
March 31, 2021 | 99.83% |
February 28, 2021 | 99.83% |
January 31, 2021 | 99.83% |
December 31, 2020 | 99.83% |
November 30, 2020 | 99.83% |
October 31, 2020 | 99.83% |
September 30, 2020 | 99.83% |
August 31, 2020 | 99.83% |
July 31, 2020 | 99.83% |
June 30, 2020 | 99.83% |
May 31, 2020 | 99.83% |
April 30, 2020 | 99.83% |
March 31, 2020 | 99.83% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.08%
Minimum
Aug 2023
99.83%
Maximum
May 2019
99.59%
Average
99.83%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -74.29 |
Beta (5Y) | 1.596 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 115.9% |
Historical Sharpe Ratio (5Y) | -0.4874 |
Historical Sortino (5Y) | -1.210 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.71% |